IgD monoclonal gammopathy with long‐term follow‐up
- 1 October 1994
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 88 (2), 395-396
- https://doi.org/10.1111/j.1365-2141.1994.tb05037.x
Abstract
The presence of a serum IgD monoclonal protein (M-protein) is usually indicative of a malignant plasma cell disorder. However, one case of well-documented benign monoclonal gammopathy (BMG) of IgD type has been reported. We describe another patient with IgD monoclonal gammopathy of undetermined significance (MGUS) with long-term follow-up. In this patient an IgD lambda M-protein was found on routine serum electrophoresis. She is alive and has no evidence of multiple myeloma or amyloidosis after 8 years of follow-up. Although IgD MGUS is exceedingly rare, this case demonstrates that the presence of a serum IgD M-protein is not necessarily synonymous with a malignant plasma cell process.Keywords
This publication has 10 references indexed in Scilit:
- “Benign” Monoclonal Gammopathy—After 20 to 35 Years of Follow-UpMayo Clinic Proceedings, 1993
- Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significanceBritish Journal of Haematology, 1992
- Immunoglobulin D benign monoclonal gammopathy. A case reportCancer, 1991
- IgD-λ monoclonal gammaopathy and axonal neuropathyJournal of Internal Medicine, 1989
- 'Benign' Monoclonal GammopathyPublished by American Medical Association (AMA) ,1984
- Idiopathic Bence Jones ProteinuriaNew England Journal of Medicine, 1982
- Monoclonal gammopathy of undetermined significanceAmerican Journal Of Medicine, 1978
- Immunochemical Classes of Myelomatosis. INCLUDING DATA FROM A THERAPEUTIC TRIAL CONDUCTED BY A MEDICAL RESEARCH COUNCIL WORKING PARTYBritish Journal of Haematology, 1969
- Younger Age of Presentation and Extraosseous Tumour in IgD MyelomatosisBMJ, 1969